Registrant : Organisation or self-employed individual
| Name/company name: |
Baxter Healthcare SA |
| Acronym: |
Baxter
|
| Legal status: |
Corporation
|
| Website address: |
http://www.baxter.com
|
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
Pierre Destexhe
|
| Position: |
Associate General Counsel |
Permanent person in charge of EU relations
| Surname, Name: |
Mr
Toon Digneffe
|
| Position: |
Director Government Affairs and Public Policy, European Affairs |
Contact details:
| Contact details of organisation's head office: |
130 Thurgauerstrasse Glattpark
Zurich 8152
SWITZERLAND
|
| Telephone number: |
(+41) 448786000 |
| Fax number: |
(+41) 448786350 |
| Other contact information: |
Baxter Brussels office to the European Union:
Baxter World Trade sprl
Alliance Park
Boulevard d'Angleterre 2-4
1420 Braine l'Alleud
|
Goals / remit
| Goals / remit of the organisation: |
Description:
Baxter manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Baxter employs about 47,600 employees.
One of Baxter's competitive strengths is its diverse technological expertise and commitment to scientific innovation. The company's unique combination of capabilities in medical devices, pharmaceuticals and biotechnology, including specialty biologics, sets it apart from other companies in the healthcare industry.
Goals:
• Baxter interacts with the EU Institutions on the legislation which has an impact on the healthcare industry through its participation in debates and public consultations
• Ensure equal access to treatment and innovative medicines to patients
• Apply innovative science to develop specialty therapeutics and medical products that save and sustain patients’ lives
• Improve conditions for prevention, treatment and care to address unmet needs
• Raise awareness and support the voice of patients suffering from chronic and life threatening diseases
• Support policy development aiming at improving regulatory processes for the healthcare sector and the competitiveness of research and industry
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
3
|
|
Complementary information:
|
|
Persons accredited for access to European Parliament premises
| First name
|
Surname
|
Start Date |
End Date |
|
Toon
|
DIGNEFFE
|
12/03/13
|
08/03/14
|
|
Frederik
|
ULRICHS
|
19/03/13
|
15/03/14
|
|
Maria
|
RODRIGUEZ SANCHEZ
|
12/03/13
|
08/03/14
|
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
Many projects in the healthcare policy and market access arena at large including the following EU legislative files:
- Crossborder Healthcare
- MDD recast
- Information to Patients
- REACH
- Falsified Medicines / Counterfeiting
- RoHS
- GPP
- Packaging
- E-Health
- E-Commerce / E-procurement
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Competition
- Consumer Affairs
- Economic and Financial Affairs
- Energy
- Enterprise
- Environment
- Information Society
- Public Health
- Research and Technology
- Taxation
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
EFPIA, Eucomed, EBE, EVM, Europabio, PPTA, Amcham EU
|
Financial data
| Financial year: |
01/2011
-
12/2011
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
450000
€ - 500000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
|
|
